Liverpool Skylilne

Pharmacy and Biomolecular Sciences

Dr Raida Al Kassas

Dr Raida Al Kassas

Telephone: 0151 904 6185

Publications

Highlighted publications

Hsi S-L, Surman P, Al-Kassas R. 2019. Development of a stability-indicating UPLC method for determination of isotretinoin in bulk drug PHARMACEUTICAL DEVELOPMENT AND TECHNOLOGY, 24 :189-198 >DOI >Link

Al-Kassas R, Bansal M, Shaw J. 2017. Nanosizing techniques for improving bioavailability of drugs JOURNAL OF CONTROLLED RELEASE, 260 :202-212 >DOI >Link

Cerqueira BBS, Lasham A, Shelling AN, Al-Kassas R. 2017. Development of biodegradable PLGA nanoparticles surface engineered with hyaluronic acid for targeted delivery of paclitaxel to triple negative breast cancer cells MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS, 76 :593-600 >DOI >Link

Seyfoddin A, Sherwin T, Patel DV, McGhee CN, Rupenthal ID, Taylor JA, Al-Kassas R. 2016. Ex vivo and In vivo Evaluation of Chitosan Coated Nanostructured Lipid Carriers for Ocular Delivery of Acyclovir CURRENT DRUG DELIVERY, 13 :923-934 >DOI >Link

Al-Kassas R, Wen J, Cheng AE-M, Kim AM-J, Liu SSM, Yu J. 2016. Transdermal delivery of propranolol hydrochloride through chitosan nanoparticles dispersed in mucoadhesive gel CARBOHYDRATE POLYMERS, 153 :176-186 >DOI >Link

Alzaher W, Shaw J, Al-Kassas R. 2016. Gastroretentive Formulations for Improving Oral Bioavailability of Drugs-Focus on Microspheres and their Production CURRENT DRUG DELIVERY, 13 :646-661 >DOI >Link

Duxfield L, Sultana R, Wang R, Englebretsen V, Deo S, Rupenthal ID, Al-Kassas R. 2016. Ocular delivery systems for topical application of anti-infective agents DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 42 :1-11 >DOI >Link

Duxfield L, Sultana R, Wang R, Englebretsen V, Deo S, Swift S, Rupenthal I, Al-Kassas R. 2016. Development of gatifloxacin-loaded cationic polymeric nanoparticles for ocular drug delivery PHARMACEUTICAL DEVELOPMENT AND TECHNOLOGY, 21 :172-179 >DOI >Link

Cerqueira BBS, Lasham A, Shelling AN, Al-Kassas R. 2015. Nanoparticle therapeutics: Technologies and methods for overcoming cancer EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 97 :140-151 >DOI >Link

Tharkar P, Madani AU, Lasham A, Shelling AN, Al-Kassas R. 2015. Nanoparticulate carriers: an emerging tool for breast cancer therapy JOURNAL OF DRUG TARGETING, 23 :97-108 >DOI >Link

Madni A, Sarfraz M, Rehman M, Ahmad M, Akhtar N, Ahmad S, Tahir N, Ijaz S, Al-Kassas R, Loebenberg R. 2014. Liposomal Drug Delivery: A Versatile Platform for Challenging Clinical Applications JOURNAL OF PHARMACY AND PHARMACEUTICAL SCIENCES, 17 :401-426 >DOI >Link

Kuntworbe N, Ofori M, Addo P, Tingle M, Al-Kassas R. 2013. Pharmacokinetics and in vivo chemosuppressive activity studies on cryptolepine hydrochloride and cryptolepine hydrochloride-loaded gelatine nanoformulation designed for parenteral administration for the treatment of malaria ACTA TROPICA, 127 :165-173 >DOI >Link

Kuntworbe N, Alany RG, Brimble M, Al-Kassas R. 2013. Determination of pKa and forced degradation of the indoloquinoline antimalarial compound cryptolepine hydrochloride PHARMACEUTICAL DEVELOPMENT AND TECHNOLOGY, 18 :866-876 >DOI >Link

Awasthi A, Razzak M, Al-Kassas R, Harvey J, Garg S. 2013. Evaluation of degradation kinetics for abamectin in formulations using a stability indicating method ACTA PHARMACEUTICA, 63 :59-69 >DOI >Link

Seyfoddin A, Al-Kassas R. 2013. Development of solid lipid nanoparticles and nanostructured lipid carriers for improving ocular delivery of acyclovir DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 39 :508-519 >DOI >Link

Journal article

Hsi S-L, Surman P, Al-Kassas R. 2019. Development of a stability-indicating UPLC method for determination of isotretinoin in bulk drug PHARMACEUTICAL DEVELOPMENT AND TECHNOLOGY, 24 :189-198 >DOI >Link

Al-Kassas R, Bansal M, Shaw J. 2017. Nanosizing techniques for improving bioavailability of drugs JOURNAL OF CONTROLLED RELEASE, 260 :202-212 >DOI >Link

Cerqueira BBS, Lasham A, Shelling AN, Al-Kassas R. 2017. Development of biodegradable PLGA nanoparticles surface engineered with hyaluronic acid for targeted delivery of paclitaxel to triple negative breast cancer cells MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS, 76 :593-600 >DOI >Link

Seyfoddin A, Sherwin T, Patel DV, McGhee CN, Rupenthal ID, Taylor JA, Al-Kassas R. 2016. Ex vivo and In vivo Evaluation of Chitosan Coated Nanostructured Lipid Carriers for Ocular Delivery of Acyclovir CURRENT DRUG DELIVERY, 13 :923-934 >DOI >Link

Al-Kassas R, Wen J, Cheng AE-M, Kim AM-J, Liu SSM, Yu J. 2016. Transdermal delivery of propranolol hydrochloride through chitosan nanoparticles dispersed in mucoadhesive gel CARBOHYDRATE POLYMERS, 153 :176-186 >DOI >Link

Alzaher W, Shaw J, Al-Kassas R. 2016. Gastroretentive Formulations for Improving Oral Bioavailability of Drugs-Focus on Microspheres and their Production CURRENT DRUG DELIVERY, 13 :646-661 >DOI >Link

Duxfield L, Sultana R, Wang R, Englebretsen V, Deo S, Rupenthal ID, Al-Kassas R. 2016. Ocular delivery systems for topical application of anti-infective agents DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 42 :1-11 >DOI >Link

Duxfield L, Sultana R, Wang R, Englebretsen V, Deo S, Swift S, Rupenthal I, Al-Kassas R. 2016. Development of gatifloxacin-loaded cationic polymeric nanoparticles for ocular drug delivery PHARMACEUTICAL DEVELOPMENT AND TECHNOLOGY, 21 :172-179 >DOI >Link

Cerqueira BBS, Lasham A, Shelling AN, Al-Kassas R. 2015. Nanoparticle therapeutics: Technologies and methods for overcoming cancer EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 97 :140-151 >DOI >Link

Tharkar P, Madani AU, Lasham A, Shelling AN, Al-Kassas R. 2015. Nanoparticulate carriers: an emerging tool for breast cancer therapy JOURNAL OF DRUG TARGETING, 23 :97-108 >DOI >Link

Madni A, Sarfraz M, Rehman M, Ahmad M, Akhtar N, Ahmad S, Tahir N, Ijaz S, Al-Kassas R, Loebenberg R. 2014. Liposomal Drug Delivery: A Versatile Platform for Challenging Clinical Applications JOURNAL OF PHARMACY AND PHARMACEUTICAL SCIENCES, 17 :401-426 >DOI >Link

Svirskis D, Seyfoddin A, Chalabi S, Kim JHI, Langford C, Painter S, Al-Kassas R. 2014. Development of mucoadhesive floating hollow beads of acyclovir with gastroretentive properties PHARMACEUTICAL DEVELOPMENT AND TECHNOLOGY, 19 :571-576 >DOI >Link

Kuntworbe N, Ofori M, Addo P, Tingle M, Al-Kassas R. 2013. Pharmacokinetics and in vivo chemosuppressive activity studies on cryptolepine hydrochloride and cryptolepine hydrochloride-loaded gelatine nanoformulation designed for parenteral administration for the treatment of malaria ACTA TROPICA, 127 :165-173 >DOI >Link

Kuntworbe N, Alany RG, Brimble M, Al-Kassas R. 2013. Determination of pKa and forced degradation of the indoloquinoline antimalarial compound cryptolepine hydrochloride PHARMACEUTICAL DEVELOPMENT AND TECHNOLOGY, 18 :866-876 >DOI >Link

Awasthi A, Razzak M, Al-Kassas R, Harvey J, Garg S. 2013. Evaluation of degradation kinetics for abamectin in formulations using a stability indicating method ACTA PHARMACEUTICA, 63 :59-69 >DOI >Link

Seyfoddin A, Al-Kassas R. 2013. Development of solid lipid nanoparticles and nanostructured lipid carriers for improving ocular delivery of acyclovir DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 39 :508-519 >DOI >Link

Awasthi A, Razzak M, Al-Kassas R, Greenwood DR, Harvey J, Garg S. 2012. Isolation and characterization of degradation products of moxidectin using LC, LTQ FT-MS, H/D exchange and NMR ANALYTICAL AND BIOANALYTICAL CHEMISTRY, 404 :2203-2222 >DOI >Link

Awasthi A, Razzak M, Al-Kassas R, Greenwood DR, Harvey J, Garg S. 2012. Separation and Identification of Degradation Products in Abamectin Formulation Using LC, LTQ FT-MS, H/D Exchange and NMR CURRENT PHARMACEUTICAL ANALYSIS, 8 :415-430 >DOI >Link

Awasthi A, Razzak M, Al-Kassas R, Harvey J, Garg S. 2012. An Overview on Chemical Derivatization and Stability Aspects of Selected Avermectin Derivatives CHEMICAL & PHARMACEUTICAL BULLETIN, 60 :931-944 >DOI >Link

Kuntworbe N, Martini N, Shaw J, Al-Kassas R. 2012. Malaria Intervention Policies and Pharmaceutical Nanotechnology as a Potential Tool for Malaria Management DRUG DEVELOPMENT RESEARCH, 73 :167-184 >DOI >Link

Abdelkader H, Wu Z, Al-Kassas R, Alany RG. 2012. Niosomes and discomes for ocular delivery of naltrexone hydrochloride: Morphological, rheological, spreading properties and photo-protective effects INTERNATIONAL JOURNAL OF PHARMACEUTICS, 433 :142-148 >DOI >Link

Kuntworbe N, Al-Kassas R. 2012. Design and In Vitro Haemolytic Evaluation of Cryptolepine Hydrochloride-Loaded Gelatine Nanoparticles as a Novel Approach for the Treatment of Malaria AAPS PHARMSCITECH, 13 :568-581 >DOI >Link

Fathabadi EG, Shelling AN, Al-Kassas R. 2012. Nanocarrier systems for delivery of siRNA to ovarian cancer tissues EXPERT OPINION ON DRUG DELIVERY, 9 :743-754 >DOI >Link

Abdelkader H, Ismail S, Hussein A, Wu Z, Al-Kassas R, Alany RG. 2012. Conjunctival and corneal tolerability assessment of ocular naltrexone niosomes and their ingredients on the hen's egg chorioallantoic membrane and excised bovine cornea models INTERNATIONAL JOURNAL OF PHARMACEUTICS, 432 :1-10 >DOI >Link

Awasthi A, Razzak M, Al-Kassas R, Greenwood DR, Harvey J, Garg S. 2012. Separation and identification of degradation products in eprinomectin formulation using LC, LTQ FT-MS, H/D exchange, and NMR JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 63 :62-73 >DOI >Link

Abdelkader H, Wu Z, Al-Kassas R, Brown JE, Alany RG. 2011. Preformulation characteristics of the opioid growth factor antagonist-naltrexone hydrochloride: stability and lipophilicity studies JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY, 21 :157-163 >DOI >Link

Gupta J, Tao JQ, Garg S, Al-Kassas R. 2011. Design and Development of an <i>in Vitro</i> Assay for Evaluation of Solid Vaginal Dosage Forms Pharmacology & Pharmacy, 02 :289-298 >DOI

Al Kassas R, Kuntworbe N, Alany R, Brimble M, Martini N. 2011. Isolation and development of an HPLC method for the detection and quantification of cryptolepine and its application in the determination of the total cryptolepine content in the root powder of Cryptolepis sanguinolenta. Perry G. Pharmacology & Pharmacy, 3

Seyfoddin A, Shaw J, Al-Kassas R. 2010. Solid lipid nanoparticles for ocular drug delivery DRUG DELIVERY, 17 :467-489 >DOI >Link

Al-Kassas RS, El-Khatib MM. 2009. Ophthalmic controlled release in situ gelling systems for ciprofloxacin based on polymeric carriers DRUG DELIVERY, 16 :145-152 >DOI >Link

Al-Kassas RS, Al-Gohary OMN, Al-Faadhel MM. 2007. Controlling of systemic absorption of gliclazide through incorporation into alginate beads INTERNATIONAL JOURNAL OF PHARMACEUTICS, 341 :230-237 >DOI >Link

Al-Kassas R. 2004. Design and in vitro evaluation of gentamicin-Eudragit microspheres intended for intra-ocular administration JOURNAL OF MICROENCAPSULATION, 21 :71-81 >DOI >Link

Al-Kassas R. 2003. Interaction study between mebeverine hydrochloride, isoniazid and certain polymers used to prepare multiparticulate delivery systems using differential scanning calorimetry STP PHARMA SCIENCES, 13 :359-366 >Link

Al-Kassas RS, Rezk NJ. 2003. Enterotoxigenic E-coli colonization factor antigen (CFA/II)-loaded polyisobutylcyanoacrylate nanoparticles for oral immunization STP PHARMA SCIENCES, 13 :93-98 >Link

Safwat SM, Al-Kassas RS. 2002. Evaluation of gentamicin-Eudragit microspheres as ophthalmic delivery systems in inflamed rabbit's eyes STP PHARMA SCIENCES, 12 :357-361 >Link

Al-Gohary OMN, Al-Kassas RS. 2000. Stability studies of aspirin-magaldrate double layer tablets Pharmaceutica Acta Helvetiae, 74 :351-360 >DOI

Al Kassas R. 2000. Controlled-release theophylline suppositories containing bioadhesive microspheres Bulletin of Faculty of Pharmacy, Cairo University,

Su XY, Al-Kassas R, Li Wan Po A. 1994. Statistical modelling of ibuprofen release from spherical lipophilic matrices European Journal of Pharmaceutics and Biopharmaceutics, 40 :73-76

Al-Kassas RS, Gilligan CA, Li Wan Po A. 1993. Processing factors affecting particle size and in vitro drug release of sustained-release ibuprofen microspheres International Journal of Pharmaceutics, 94 :59-67 >DOI

Chapters

Awasthi A, Razzak M, Al-Kassas R, Harvey J, Garg S. 2013. Analytical Profile of Moxidectin Profiles of Drug Substances, Excipients and Related Methodology 38 :315-366 >DOI

Seyfoddin A, Al-Kassas R. 2011. Biodegradable polymers for controlled delivery of bioactive macromolecules Biodegradable Polymers: Processing, Degradation and Applications :471-500 9781612095349